Clinical trial management system (CTMS) market size to increase by USD 1,449.16 million between 2022 and 2027; Growth driven by increasing healthcare expenditure – Technavio

NEW YORK, March 10, 2023 /PRNewswire/ — The clinical trial management system (CTMS) market size is forecast to grow by USD 1,449.16 million between 2022 and 2027, and the growth momentum will accelerate at a CAGR of 12.81% during the forecast period. The growth of the market is driven by a rise in healthcare expenditure. The increasing prevalence of chronic diseases and rising disposable incomes have increased healthcare expenditure globally. Besides, rising awareness of early diagnosis and the need for timely medical support have made people more health conscious. This has led to an increase in spending on healthcare. All these factors are driving the growth of the global clinical trial management system market. For more insights on the historic data (2017 to 2021) and forecast market size (2023 to 2027) – Request a report sample

Regional Analysis

By region, the global clinical trial management system (CTMS) market is segmented into North America, Europe, Asia, and Rest of World (ROW). North America will account for 44% of market growth during the forecast period. The region is home to a high number of pharmaceutical and biotechnology companies and contract research organizations (CROs). In addition, the increasing prevalence of chronic diseases and the rising number of clinical trials are driving the growth of the clinical trial management system (CTMS) market in North America.

Vendor Landscape

The clinical trial management system (CTMS) market is fragmented due to the presence of diverse regional and international vendors. Regional vendors face stiff competition from international players in terms of quality, price, market reach, and financial resources. During the forecast period, the competition in the market is expected to intensify with an increase in product innovations, product and service extensions, and mergers and acquisitions.

The report includes information on the key products and recent developments of leading vendors, including ArisGlobal LLC, eResearchTechnology GmbH, Advarra Inc., Dassault Systemes SE, DATATRAK International Inc., International Business Machines Corp., Medpace Holdings Inc., Oracle Corp., Parexel International Corp., Veeva Systems Inc., Laboratory Corp. of America Holdings, DSG Inc., MasterControl Inc., Wipro Ltd., MedNet, Medfiles USA, Crucial Data Solutions Inc., Ennov SAS, RealTime Software Solutions LLC, and PHARMASEAL.

Market Dynamics

The growth of the market is driven by factors such as increasing healthcare expenditure, rise in clinical trials for drugs, and the increased adoption of CTMS. However, the rising cost of clinical trials will hinder the growth of the market.

Competitive Analysis

The competitive scenario categorizes companies based on various performance indicators. Some of the factors considered include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, and growth in market share among others. Request a Sample

Market Segmentation

• By deployment, the market is segmented into on-premise and cloud.
• By end-user, the market is segmented into pharmaceutical and biotechnology companies, CROs, and others.
• By geography, the market is segmented into North America, Europe, Asia, and Rest of World (ROW).

Why Buy?

• Add credibility to strategy
• Analyzes competitor’s offerings
• Get a holistic view of the market

Grow your profit margin with Technavio – Buy the Report!

Related Reports:

• The healthcare interoperability solution market is estimated to grow at a CAGR of 13.51% between 2022 and 2027. The size of the market is forecasted to increase by USD 3,330.16 million. The increasing adoption of EHRs is notably driving the market growth, although factors such as concerns over the security of patient data and cyberattacks may impede the market growth.
• The digital health market is estimated to grow at a CAGR of 25.8% between 2022 and 2027. The size of the market is forecast to increase by USD 563.59 billion. The increase in the number of M&A activities in the market is notably driving the market growth, although factors such as the threat of open-source service providers may impede the market growth.

Technavio’s library includes over 17,000+ reports, covering more than 2,000 emerging technologies. Subscribe to our “Basic Plan” at just USD 5,000 and get lifetime access to Technavio Insights

What are the key data covered in this clinical trial management system (CTMS) market report?

• CAGR of the market during the forecast period.
• Detailed information on factors that will drive the growth of the market between 2023 and 2027
• Precise estimation of the size of the clinical trial management system (CTMS) market and its contribution to the parent market.
• Accurate predictions about upcoming trends and changes in consumer behavior.
• Growth of the market across North America, Europe, Asia, and Rest of World (ROW).
• A thorough analysis of the market’s competitive landscape and detailed information about vendors.
• Comprehensive analysis of factors that will challenge the growth of clinical trial management system (CTMS) market vendors. 

Browse through Technavio’s Health Care Market Reports

Table of contents:

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Deployment
• Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
• Exhibit 07: Executive Summary – Chart on Incremental Growth
• Exhibit 08: Executive Summary – Data Table on Incremental Growth
• Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 13: Market segments

• 3.3 Market size 2022

• 3.4 Market outlook: Forecast for 2022-2027 
• Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global clinical trial management system (CTMS) market 2017 – 2021 
• Exhibit 18: Historic Market Size – Data Table on Global clinical trial management system (CTMS) market 2017 – 2021 ($ million)

• 4.2 Deployment Segment Analysis 2017 – 2021 
• Exhibit 19: Historic Market Size – Deployment Segment 2017 – 2021 ($ million)

• 4.3 End-user Segment Analysis 2017 – 2021 
• Exhibit 20: Historic Market Size – End-user Segment 2017 – 2021 ($ million)

• 4.4 Geography Segment Analysis 2017 – 2021 
• Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)

• 4.5 Country Segment Analysis 2017 – 2021 
• Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis – Comparison between 2022 and 2027

• 5.2 Bargaining power of buyers 
• Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

• 5.3 Bargaining power of suppliers 
• Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

• 5.4 Threat of new entrants 
• Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

• 5.5 Threat of substitutes 
• Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

• 5.7 Market condition
• Exhibit 29: Chart on Market condition – Five forces 2022 and 2027

6 Market Segmentation by Deployment

• 6.1 Market segments
• Exhibit 30: Chart on Deployment – Market share 2022-2027 (%)
• Exhibit 31: Data Table on Deployment – Market share 2022-2027 (%)

• 6.2 Comparison by Deployment 
• Exhibit 32: Chart on Comparison by Deployment
• Exhibit 33: Data Table on Comparison by Deployment

• 6.3 On-premise – Market size and forecast 2022-2027 
• Exhibit 34: Chart on On-premise – Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on On-premise – Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on On-premise – Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on On-premise – Year-over-year growth 2022-2027 (%)

• 6.4 Cloud – Market size and forecast 2022-2027 
• Exhibit 38: Chart on Cloud – Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Cloud – Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Cloud – Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Cloud – Year-over-year growth 2022-2027 (%)

• 6.5 Market opportunity by Deployment 
• Exhibit 42: Market opportunity by Deployment ($ million)

7 Market Segmentation by End-user

• 7.1 Market segments
• Exhibit 43: Chart on End-user – Market share 2022-2027 (%)
• Exhibit 44: Data Table on End-user – Market share 2022-2027 (%)

• 7.2 Comparison by End-user 
• Exhibit 45: Chart on Comparison by End-user
• Exhibit 46: Data Table on Comparison by End-user

• 7.3 Pharmaceutical and biotechnology companies – Market size and forecast 2022-2027
• Exhibit 47: Chart on Pharmaceutical and biotechnology companies – Market size and forecast 2022-2027 ($ million)
• Exhibit 48: Data Table on Pharmaceutical and biotechnology companies – Market size and forecast 2022-2027 ($ million)
• Exhibit 49: Chart on Pharmaceutical and biotechnology companies – Year-over-year growth 2022-2027 (%)
• Exhibit 50: Data Table on Pharmaceutical and biotechnology companies – Year-over-year growth 2022-2027 (%)

• 7.4 CROs – Market size and forecast 2022-2027 
• Exhibit 51: Chart on CROs – Market size and forecast 2022-2027 ($ million)
• Exhibit 52: Data Table on CROs – Market size and forecast 2022-2027 ($ million)
• Exhibit 53: Chart on CROs – Year-over-year growth 2022-2027 (%)
• Exhibit 54: Data Table on CROs – Year-over-year growth 2022-2027 (%)

• 7.5 Others – Market size and forecast 2022-2027 
• Exhibit 55: Chart on Others – Market size and forecast 2022-2027 ($ million)
• Exhibit 56: Data Table on Others – Market size and forecast 2022-2027 ($ million)
• Exhibit 57: Chart on Others – Year-over-year growth 2022-2027 (%)
• Exhibit 58: Data Table on Others – Year-over-year growth 2022-2027 (%)

• 7.6 Market opportunity by End-user 
• Exhibit 59: Market opportunity by End-user ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview 
• Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation 
• Exhibit 61: Chart on Market share by geography 2022-2027 (%)
• Exhibit 62: Data Table on Market share by geography 2022-2027 (%)

• 9.2 Geographic comparison 
• Exhibit 63: Chart on Geographic comparison
• Exhibit 64: Data Table on Geographic comparison

• 9.3 North America – Market size and forecast 2022-2027 
• Exhibit 65: Chart on North America – Market size and forecast 2022-2027 ($ million)
• Exhibit 66: Data Table on North America – Market size and forecast 2022-2027 ($ million)
• Exhibit 67: Chart on North America – Year-over-year growth 2022-2027 (%)
• Exhibit 68: Data Table on North America – Year-over-year growth 2022-2027 (%)

• 9.4 Europe – Market size and forecast 2022-2027 
• Exhibit 69: Chart on Europe – Market size and forecast 2022-2027 ($ million)
• Exhibit 70: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
• Exhibit 71: Chart on Europe – Year-over-year growth 2022-2027 (%)
• Exhibit 72: Data Table on Europe – Year-over-year growth 2022-2027 (%)

• 9.5 Asia – Market size and forecast 2022-2027 
• Exhibit 73: Chart on Asia – Market size and forecast 2022-2027 ($ million)
• Exhibit 74: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
• Exhibit 75: Chart on Asia – Year-over-year growth 2022-2027 (%)
• Exhibit 76: Data Table on Asia – Year-over-year growth 2022-2027 (%)

• 9.6 Rest of World (ROW) – Market size and forecast 2022-2027 
• Exhibit 77: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
• Exhibit 78: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
• Exhibit 79: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
• Exhibit 80: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)

• 9.7 US – Market size and forecast 2022-2027 
• Exhibit 81: Chart on US – Market size and forecast 2022-2027 ($ million)
• Exhibit 82: Data Table on US – Market size and forecast 2022-2027 ($ million)
• Exhibit 83: Chart on US – Year-over-year growth 2022-2027 (%)
• Exhibit 84: Data Table on US – Year-over-year growth 2022-2027 (%)

• 9.8 China – Market size and forecast 2022-2027 
• Exhibit 85: Chart on China – Market size and forecast 2022-2027 ($ million)
• Exhibit 86: Data Table on China – Market size and forecast 2022-2027 ($ million)
• Exhibit 87: Chart on China – Year-over-year growth 2022-2027 (%)
• Exhibit 88: Data Table on China – Year-over-year growth 2022-2027 (%)

• 9.9 Germany – Market size and forecast 2022-2027 
• Exhibit 89: Chart on Germany – Market size and forecast 2022-2027 ($ million)
• Exhibit 90: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
• Exhibit 91: Chart on Germany – Year-over-year growth 2022-2027 (%)
• Exhibit 92: Data Table on Germany – Year-over-year growth 2022-2027 (%)

• 9.10 Canada – Market size and forecast 2022-2027 
• Exhibit 93: Chart on Canada – Market size and forecast 2022-2027 ($ million)
• Exhibit 94: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
• Exhibit 95: Chart on Canada – Year-over-year growth 2022-2027 (%)
• Exhibit 96: Data Table on Canada – Year-over-year growth 2022-2027 (%)

• 9.11 UK – Market size and forecast 2022-2027 
• Exhibit 97: Chart on UK – Market size and forecast 2022-2027 ($ million)
• Exhibit 98: Data Table on UK – Market size and forecast 2022-2027 ($ million)
• Exhibit 99: Chart on UK – Year-over-year growth 2022-2027 (%)
• Exhibit 100: Data Table on UK – Year-over-year growth 2022-2027 (%)

• 9.12 Market opportunity by geography 
• Exhibit 101: Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers

• 10.2 Market challenges

• 10.3 Impact of drivers and challenges 
• Exhibit 102: Impact of drivers and challenges in 2022 and 2027

• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview

• 11.2 Vendor landscape
• Exhibit 103: Overview on Criticality of inputs and Factors of differentiation

• 11.3 Landscape disruption
• Exhibit 104: Overview on factors of disruption

• 11.4 Industry risks
• Exhibit 105: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 106: Vendors covered

• 12.2 Market positioning of vendors 
• Exhibit 107: Matrix on vendor position and classification

• 12.3 Advarra Inc.
• Exhibit 108: Advarra Inc. – Overview
• Exhibit 109: Advarra Inc. – Product / Service
• Exhibit 110: Advarra Inc. – Key offerings

• 12.4 ArisGlobal LLC
• Exhibit 111: ArisGlobal LLC – Overview
• Exhibit 112: ArisGlobal LLC – Product / Service
• Exhibit 113: ArisGlobal LLC – Key offerings

• 12.5 Dassault Systemes SE
• Exhibit 114: Dassault Systemes SE – Overview
• Exhibit 115: Dassault Systemes SE – Product / Service
• Exhibit 116: Dassault Systemes SE – Key news
• Exhibit 117: Dassault Systemes SE – Key offerings

• 12.6 DATATRAK International Inc. 
• Exhibit 118: DATATRAK International Inc. – Overview
• Exhibit 119: DATATRAK International Inc. – Product / Service
• Exhibit 120: DATATRAK International Inc. – Key news
• Exhibit 121: DATATRAK International Inc. – Key offerings

• 12.7 DSG Inc.
• Exhibit 122: DSG Inc. – Overview
• Exhibit 123: DSG Inc. – Product / Service
• Exhibit 124: DSG Inc. – Key offerings

• 12.8 eResearchTechnology GmbH 
• Exhibit 125: eResearchTechnology GmbH – Overview
• Exhibit 126: eResearchTechnology GmbH – Product / Service
• Exhibit 127: eResearchTechnology GmbH – Key offerings

• 12.9 International Business Machines Corp. 
• Exhibit 128: International Business Machines Corp. – Overview
• Exhibit 129: International Business Machines Corp. – Business segments
• Exhibit 130: International Business Machines Corp. – Key offerings
• Exhibit 131: International Business Machines Corp. – Segment focus

• 12.10 Laboratory Corp. of America Holdings 
• Exhibit 132: Laboratory Corp. of America Holdings – Overview
• Exhibit 133: Laboratory Corp. of America Holdings – Business segments
• Exhibit 134: Laboratory Corp. of America Holdings – Key news
• Exhibit 135: Laboratory Corp. of America Holdings – Key offerings
• Exhibit 136: Laboratory Corp. of America Holdings – Segment focus

• 12.11 MasterControl Inc.
• Exhibit 137: MasterControl Inc. – Overview
• Exhibit 138: MasterControl Inc. – Product / Service
• Exhibit 139: MasterControl Inc. – Key offerings

• 12.12 MedNet
• Exhibit 140: MedNet – Overview
• Exhibit 141: MedNet – Product / Service
• Exhibit 142: MedNet – Key offerings

• 12.13 Medpace Holdings Inc. 
• Exhibit 143: Medpace Holdings Inc. – Overview
• Exhibit 144: Medpace Holdings Inc. – Product / Service
• Exhibit 145: Medpace Holdings Inc. – Key offerings

• 12.14 Oracle Corp.
• Exhibit 146: Oracle Corp. – Overview
• Exhibit 147: Oracle Corp. – Business segments
• Exhibit 148: Oracle Corp. – Key news
• Exhibit 149: Oracle Corp. – Key offerings
• Exhibit 150: Oracle Corp. – Segment focus

• 12.15 Parexel International Corp. 
• Exhibit 151: Parexel International Corp. – Overview
• Exhibit 152: Parexel International Corp. – Product / Service
• Exhibit 153: Parexel International Corp. – Key news
• Exhibit 154: Parexel International Corp. – Key offerings

• 12.16 Veeva Systems Inc.
• Exhibit 155: Veeva Systems Inc. – Overview
• Exhibit 156: Veeva Systems Inc. – Business segments
• Exhibit 157: Veeva Systems Inc. – Key offerings
• Exhibit 158: Veeva Systems Inc. – Segment focus

• 12.17 Wipro Ltd.
• Exhibit 159: Wipro Ltd. – Overview
• Exhibit 160: Wipro Ltd. – Business segments
• Exhibit 161: Wipro Ltd. – Key news
• Exhibit 162: Wipro Ltd. – Key offerings
• Exhibit 163: Wipro Ltd. – Segment focus

13 Appendix

• 13.1 Scope of the report

• 13.2 Inclusions and exclusions checklist 
• Exhibit 164: Inclusions checklist
• Exhibit 165: Exclusions checklist

• 13.3 Currency conversion rates for US$ 
• Exhibit 166: Currency conversion rates for US$

• 13.4 Research methodology
• Exhibit 167: Research methodology
• Exhibit 168: Validation techniques employed for market sizing
• Exhibit 169: Information sources

• 13.5 List of abbreviations 
• Exhibit 170: List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/clinical-trial-management-system-ctms-market-size-to-increase-by-usd-1-449-16-million-between-2022-and-2027-growth-driven-by-increasing-healthcare-expenditure—technavio-301768152.html

SOURCE Technavio

PR Newswire Science News